
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Human Genetics, Roche Molecular Systems, Alameda, California 94501 [P. E. G., J. R. K.]; Environmental Epidemiology Branch, National Cancer Institute, Rockville, Maryland 20852-7234 [P. E. G., J. V. L., L. A. B., A. H.]; Lombardi Cancer Center, Georgetown University, Washington, DC 20057 [W. A. B.]; Graduate Hospital, Philadelphia, Pennsylvania 19146 [M. D. G.]; Westat, Inc., Rockville, Maryland 20850 [S. M. G.]; Yale University School of Medicine, New Haven, Connecticut 06520 [O. C. H., P. E. S.]; George Washington University, Washington, DC 20052 [L. M.]; and Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033 [R. M., R. Z.]
As human papillomavirus (HPV) becomes accepted as the central cause of
cervical cancer, longitudinal studies are shifting focus away from
causality to a more detailed investigation of the natural history of
HPV infections. These studies commonly require repeated samples for HPV
testing over several years, usually collected during a pelvic
exam, which is inconvenient to the participants and costly to the
study. To alleviate the inconvenience and cost of repeated clinic
visits, it has been proposed that women collect cervicovaginal cells
themselves, hopefully increasing participation in the natural history
studies. We evaluated the technical feasibility of self-collection of
cervicovaginal cells using a Dacron swab for HPV DNA detection. We
compared the self-collected swab sample and two clinician-administered
swab samples (one from the endocervix and another from the ectocervix)
from a total of 268 women participating in a case-control study of
adenocarcinoma and squamous cell carcinomas of the uterine cervix (111
cases and 157 controls). HPV DNA was detected and genotyped using an L1
consensus PCR assay. The overall agreement between the clinician- and
self-collected swabs was excellent [88.1%;
= 0.73 (95%
confidence interval (CI), 0.610.85)]. The correlation was highest
between the two clinician-administered swabs [
= 0.81 (95%
CI, 0.690.93)] but was still excellent when comparing either
clinician-administered swab to the self-administered sample [
= 0.75 (95% CI, 0.630.87) and 0.67 (95% CI, 0.550.79) for
ectocervix and endocervix, respectively]. The type-specific agreement
between samples was higher for high-risk, or cancer-associated, HPV
genotypes than for low risk, noncancer-associated HPV genotypes when
comparing the self-administered swab sample to the
clinician-administered swab sample (
= 0.78 for high-risk
versus 0.66 for low-risk HPV infections,
t = -1.45, P = 0.15). The
decrease in agreement for low risk types was largely attributable to an
increased detection of these types in the self-administered sample
(McNemars
2 = 6.25, P = 0.01
for clinician- versus self-administered swab
comparisons). The agreement did not vary significantly by age,
menopausal status, case status, or clinic center. We have demonstrated
that a self-collected Dacron swab sample of cervicovaginal cells is a
technically feasible alternative to clinician-administered cervical
cell collection in natural history studies of HPV and cervical cancer.
This article has been cited by other articles:
![]() |
S. T. Lindau, M. L. Drum, E. Gaumer, H. Surawska, and J. A. Jordan Prevalence of High-Risk Human Papillomavirus Among Older Women Obstet. Gynecol., November 1, 2008; 112(5): 979 - 989. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. De Alba, H. Anton-Culver, F. A. Hubbell, A. Ziogas, J. R. Hess, A. Bracho, C. Arias, and A. Manetta Self-Sampling for Human Papillomavirus in a Community Setting: Feasibility in Hispanic Women Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2163 - 2168. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Safaeian, M Kiddugavu, P E Gravitt, S J Gange, J Ssekasanvu, D Murokora, M Sklar, D Serwadda, M J Wawer, K V Shah, et al. Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda Sex Transm Inf, August 1, 2008; 84(4): 306 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Safaeian, M. Kiddugavu, P. E. Gravitt, S. J. Gange, J. Ssekasanvu, D. Murokora, M. Sklar, D. Serwadda, M. J. Wawer, K. V. Shah, et al. Determinants of Incidence and Clearance of High-Risk Human Papillomavirus Infections in Rural Rakai, Uganda Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1300 - 1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Kahn, D. Lan, and R. S. Kahn Sociodemographic Factors Associated With High-Risk Human Papillomavirus Infection Obstet. Gynecol., July 1, 2007; 110(1): 87 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Feng, S. E. Hawes, J. E. Stern, A. Dem, P. S. Sow, B. Dembele, P. Toure, P. Sova, P. W. Laird, and N. B. Kiviat Promoter Hypermethylation of Tumor Suppressor Genes in Urine from Patients with Cervical Neoplasia Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1178 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Jones, B. R. Allan, J. H. H. M. van de Wijgert, L. Altini, S. M. Taylor, A. de Kock, N. Coetzee, and A.-L. Williamson Agreement between Self- and Clinician-Collected Specimen Results for Detection and Typing of High-Risk Human Papillomavirus in Specimens from Women in Gugulethu, South Africa J. Clin. Microbiol., June 1, 2007; 45(6): 1679 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Dunne, E. R. Unger, M. Sternberg, G. McQuillan, D. C. Swan, S. S. Patel, and L. E. Markowitz Prevalence of HPV Infection Among Females in the United States JAMA, February 28, 2007; 297(8): 813 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fakhry, G. D'souza, E. Sugar, K. Weber, E. Goshu, H. Minkoff, R. Wright, E. Seaberg, and M. Gillison Relationship between Prevalent Oral and Cervical Human Papillomavirus Infections in Human Immunodeficiency Virus-Positive and -Negative Women J. Clin. Microbiol., December 1, 2006; 44(12): 4479 - 4485. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-J. van Doorn, A. Molijn, B. Kleter, W. Quint, and B. Colau Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J. Clin. Microbiol., September 1, 2006; 44(9): 3292 - 3298. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. T. P. Brink, C. J. L. M. Meijer, M. A. H. M. Wiegerinck, T. E. Nieboer, R. F. P. M. Kruitwagen, F. van Kemenade, N. Fransen Daalmeijer, A. T. Hesselink, J. Berkhof, and P. J. F. Snijders High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush. J. Clin. Microbiol., July 1, 2006; 44(7): 2518 - 2523. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Shew, J. D. Fortenberry, W. Tu, B. E. Juliar, B. E. Batteiger, B. Qadadri, and D. R. Brown Association of Condom Use, Sexual Behaviors, and Sexually Transmitted Infections With the Duration of Genital Human Papillomavirus Infection Among Adolescent Women Arch Pediatr Adolesc Med, February 1, 2006; 160(2): 151 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Castle, J. Jeronimo, M. Schiffman, R. Herrero, A. C. Rodriguez, M. C. Bratti, A. Hildesheim, S. Wacholder, L. R. Long, L. Neve, et al. Age-Related Changes of the Cervix Influence Human Papillomavirus Type Distribution Cancer Res., January 15, 2006; 66(2): 1218 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D'Souza, E. Sugar, W. Ruby, P. Gravitt, and M. Gillison Analysis of the Effect of DNA Purification on Detection of Human Papillomavirus in Oral Rinse Samples by PCR J. Clin. Microbiol., November 1, 2005; 43(11): 5526 - 5535. [Abstract] [Full Text] [PDF] |
||||
![]() |
G S Ogilvie, D M Patrick, M Schulzer, J W Sellors, M Petric, K Chambers, R White, and J M FitzGerald Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis Sex Transm Inf, June 1, 2005; 81(3): 207 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Kahn Self-testing for human papillomavirus using a vaginal swab: placing prevention of cervical cancer in the patient's hands Ann. Onc., June 1, 2004; 15(6): 847 - 849. [Full Text] [PDF] |
||||
![]() |
A. Widschwendter, C. Gattringer, L. Ivarsson, H. Fiegl, A. Schneitter, A. Ramoni, H. M. Muller, A. Wiedemair, S. Jerabek, E. Muller-Holzner, et al. Analysis of Aberrant DNA Methylation and Human Papillomavirus DNA in Cervicovaginal Specimens to Detect Invasive Cervical Cancer and Its Precursors Clin. Cancer Res., May 15, 2004; 10(10): 3396 - 3400. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Burk, M. Terai, P. E. Gravitt, L. A. Brinton, R. J. Kurman, W. A. Barnes, M. D. Greenberg, O. C. Hadjimichael, L. Fu, L. McGowan, et al. Distribution of Human Papillomavirus Types 16 and 18 Variants in Squamous Cell Carcinomas and Adenocarcinomas of the Cervix Cancer Res., November 1, 2003; 63(21): 7215 - 7220. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Garcia, B. Barker, C. Santos, E. M. Brown, T. Nuno, A. Giuliano, and J. Davis Cross-sectional Study of Patient- and Physician-Collected Cervical Cytology and Human Papillomavirus Obstet. Gynecol., August 1, 2003; 102(2): 266 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iftner and L. L. Villa Chapter 12: Human Papillomavirus Technologies J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 80 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Solomon Chapter 14: Role of Triage Testing in Cervical Cancer Screening J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 97 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
C S Herrington Self testing for human papillomaviruses J. Clin. Pathol., June 1, 2002; 55(6): 408 - 409. [Full Text] [PDF] |
||||
![]() |
F X Bosch, A Lorincz, N Munoz, C J L M Meijer, and K V Shah The causal relation between human papillomavirus and cervical cancer J. Clin. Pathol., April 1, 2002; 55(4): 244 - 265. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |